Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Vertex Pharmaceuticals Inc (NASDAQ:VRTX)

134.05
Delayed Data
As of Aug 28
 +0.30 / +0.22%
Today’s Change
90.99
Today|||52-Week Range
143.45
+12.84%
Year-to-Date

Today’s Trading

Previous close133.75
Today’s open132.39
Day’s range131.03 - 134.53
Volume1,240,196
Average volume (3 months)1,600,230
Market cap$32.8B
Dividend yield--
Data as of 4:14pm ET, 08/28/2015

Growth & Valuation

Earnings growth (last year)-58.59%
Earnings growth (this year)+30.39%
Earnings growth (next 5 years)+19.00%
Revenue growth (last year)-52.11%
P/E ratioNM
Price/Sales48.16
Price/Book30.15

Competitors

 Today’s
change
Today’s
% change
PRGOPerrigo Company PLC-2.77-1.47%
ALXNAlexion Pharmaceutic...-0.96-0.53%
MYLMylan NV-1.12-2.18%
ZTSZoetis Inc-0.08-0.17%
Data as of 4:14pm ET, 08/28/2015

Financials

Next reporting dateOctober 27, 2015
EPS forecast (this quarter)-$0.49
Annual revenue (last year)$580.4M
Annual profit (last year)-$738.6M
Net profit margin-127.09%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Jeffrey M. Leiden
SVP &
GM-International Commercial Operations
Simon Bedson
Corporate headquarters
Boston, Massachusetts

Forecasts

Partner Offers